By Manik Singal, Director, Mediwell Pharmacia · Updated 14 November 2026
What revised Schedule M and recent CDSCO directions expect when manufacturers buy and test raw materials, plus a vendor qualification checklist.
Good Manufacturing Practice (GMP) is the set of rules that makes sure medicines are produced and controlled consistently to the quality their licence requires. Much of GMP is about what happens inside your plant, but a large part starts before material reaches you: the quality of a finished product can never be better than the quality of the APIs, excipients and solvents that go into it.
Schedule M of the Drugs Rules, 1945 sets out GMP for manufacturers in India. A revised Schedule M was notified on 28 December 2023 to bring Indian GMP closer to WHO standards. It applied first to large manufacturers, and the deadline for small and medium manufacturers (turnover up to ₹250 crore) was extended to 31 December 2025. It now applies to every licensed manufacturing unit.
For raw materials, the revised schedule expects a pharmaceutical quality system with documented risk management, written specifications for every starting material, approval of suppliers before use, testing of incoming batches, proper storage and status labelling, and regular review of supplier performance.
After cough syrups contaminated with diethylene glycol (DEG) were linked to the deaths of children in 2025, the Central Drugs Standard Control Organisation (CDSCO) wrote to all state drug controllers. Inspections had found manufacturers who were not testing every batch of excipients before use. On 27 October 2026 CDSCO reiterated that manufacturers must test every batch or lot of raw materials, naming propylene glycol, glycerol and sorbitol as critical excipients, test every batch of finished product, and buy raw materials only from reliable, qualified vendors. These are existing legal requirements under the Drugs Rules, not new ones, but enforcement has clearly become stricter.
A trader does not make the material, but it is responsible for keeping it as the manufacturer released it. That means supplying in the manufacturer's original sealed packing, never relabelling or repacking without the right licence, storing material in the conditions on the label, keeping batch-wise records of what was bought and sold, and passing on the manufacturer's documents without alteration. Ask any trader you buy from how they do each of these.
We sell under wholesale drug licences in Forms 20B (HP-SOB-28247) and 21B (HP-SOB-28248) and invoice under GSTIN 02AAPCM3559C1ZL. We supply in manufacturers' original packing with their COA and MSDS, and we share licence copies and supplier details for your vendor qualification file. Your QC team should still test each batch on receipt, as the rules require.
Get competitive pricing and complete documentation. We respond within 24 hours.
Request a Quote